Study blood tests to understand organ injury in children with sepsis
Part of Infections clinical trials.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be under 18 years old.
- For the sepsis group: you must meet the study’s definition of sepsis (as confirmed by the study team).
- For the control group: you must be scheduled for an elective surgery and need a pre-surgery blood draw or an IV placed for that surgery.
- You should not have congenital (present at birth) heart disease.
- You should not be on long-term immune-suppressing medicine (like daily steroids) or have a known immune deficiency.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study looks at a specific blood protein level in children from birth to age 17. It compares healthy children and those with sepsis to see if the protein changes during infection.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at abnormal immune cells (from the bone marrow) in people with sepsis or severe trauma with shock. It aims to understand why the body’s immune response gets out of balance, which could help guide future treatments.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.